Following the GBS disease outbreak with cases reported in clusters from Sinhgad Road, Nande Village, Kirkitwadi, Dhayari and DSK Vishwa amongst other areas the State government and PMC issued directio ...

Granules India's subsidiary, GPI, receives USFDA approval for Lisdexamfetamine Dimesylate Capsules, expanding ADHD treatment ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and ...

Indian generic drugmaker Dr Reddy's Laboratories on Thursday said it was optimistic about the Donald Trump administration, as it believes the country would have an edge amid tensions between the ...